CHRISTIE BALLANTYNE to Aza Compounds
This is a "connection" page, showing publications CHRISTIE BALLANTYNE has written about Aza Compounds.
Connection Strength
0.257
-
Phase 2b Randomized Trial of the Oral PCSK9 Inhibitor MK-0616. J Am Coll Cardiol. 2023 04 25; 81(16):1553-1564.
Score: 0.197
-
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide. N Engl J Med. 2026 Feb 05; 394(6):529-539.
Score: 0.060